Brief: Promising Signals Of Effect In Annexin's RVO-Study
Aug 11 (Reuters) - Annexin Pharmaceuticals AB (publ)
ANNX.ST :
* PROMISING SIGNALS OF EFFECT IN ANNEXIN'S RVO-STUDY
* OBSERVATIONS ARE INTERESTING AND INDICATE THAT ANXV MAY
HAVE A
POSITIVE EFFECT ON COURSE OF DISEASE IN RVO
Further company coverage: ANNX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on Annexin Pharmaceuticals AB (publ)
See all newsBrief: Annexin Pharmaceuticals Q3 Net Loss At SEK 9.5 Mln
Brief: Annexin Pharmaceuticals Q2 2026 Net Loss SEK 11.6 Mln
Brief: Annexin Pharmaceuticals Gets International Nonproprietary Name Drug Candidate Anxv
Brief: Annexin Pharmaceuticals Updates On Nine Patients Treated In Nexus Study
Brief: Annexin's Rights Issue 98% Subscribed